Wednesday, February 08, 2012 11:54:30 AM
Also, on company folks selling shares in the tens of millions, maybe a few hundred million, as complained about here, shouldn't we be focusing on the fact that investors are buying that stock? I'm no expert on the alleged manipulations, but I bought BIEL shares because I have first-hand experience that Actipatch worked on a badly sprained ankle and amazingly without painkillers.
The only other questions that come to mind on the FDA applications are; (1)is it a question of fees to the FDA remaining unpaid?, (2) was someone at BIEL abrasive with someone at the FDA?, and (3) is the absence of a ruling necessarily negative? If the answers to these last 3 are all a no, then aren't we okay and we just need to be patient? Thanks to you or anyone else for helping me understand.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM